Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Statistics

Total Valuation

STO:CLS.B has a market cap or net worth of SEK 165.51 million. The enterprise value is 140.78 million.

Market Cap	165.51M
Enterprise Value	140.78M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:CLS.B has 31.17 million shares outstanding. The number of shares has increased by 134.96% in one year.

Current Share Class	31.17M
Shares Outstanding	31.17M
Shares Change (YoY)	+134.96%
Shares Change (QoQ)	+20.26%
Owned by Insiders (%)	10.68%
Owned by Institutions (%)	11.95%
Float	27.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.46
PB Ratio	2.49
P/TBV Ratio	2.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.38
EV / Sales	8.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.92

Financial Position

The company has a current ratio of 3.91

Current Ratio	3.91
Quick Ratio	2.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-310.49

Financial Efficiency

Return on equity (ROE) is -63.63% and return on invested capital (ROIC) is -27.56%.

Return on Equity (ROE)	-63.63%
Return on Assets (ROA)	-23.53%
Return on Invested Capital (ROIC)	-27.56%
Return on Capital Employed (ROCE)	-43.90%
Weighted Average Cost of Capital (WACC)	4.07%
Revenue Per Employee	1.35M
Profits Per Employee	-3.20M
Employee Count	13
Asset Turnover	0.23
Inventory Turnover	0.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.37% in the last 52 weeks. The beta is -0.03, so STO:CLS.B's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	+54.37%
50-Day Moving Average	7.33
200-Day Moving Average	6.52
Relative Strength Index (RSI)	37.51
Average Volume (20 Days)	210,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLS.B had revenue of SEK 17.49 million and -41.61 million in losses. Loss per share was -1.61.

Revenue	17.49M
Gross Profit	10.92M
Operating Income	-29.19M
Pretax Income	-42.05M
Net Income	-41.61M
EBITDA	-26.60M
EBIT	-29.19M
Loss Per Share	-1.61

Balance Sheet

The company has 21.55 million in cash and n/a in debt, with a net cash position of 21.55 million or 0.69 per share.

Cash & Cash Equivalents	21.55M
Total Debt	n/a
Net Cash	21.55M
Net Cash Per Share	0.69
Equity (Book Value)	66.48M
Book Value Per Share	2.24
Working Capital	29.12M

Cash Flow

In the last 12 months, operating cash flow was -33.20 million and capital expenditures -2.70 million, giving a free cash flow of -35.91 million.

Operating Cash Flow	-33.20M
Capital Expenditures	-2.70M
Free Cash Flow	-35.91M
FCF Per Share	-1.15

Margins

Gross margin is 62.44%, with operating and profit margins of -166.90% and -237.96%.

Gross Margin	62.44%
Operating Margin	-166.90%
Pretax Margin	-240.44%
Profit Margin	-237.96%
EBITDA Margin	-152.12%
EBIT Margin	-166.90%
FCF Margin	n/a

Dividends & Yields

STO:CLS.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-134.96%
Shareholder Yield	-134.96%
Earnings Yield	-25.14%
FCF Yield	-21.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2024. It was a reverse split with a ratio of 0.005.

Last Split Date	Apr 25, 2024
Split Type	Reverse
Split Ratio	0.005

Scores

STO:CLS.B has an Altman Z-Score of 7.26 and a Piotroski F-Score of 3.

Altman Z-Score	7.26
Piotroski F-Score	3